Impact Healthcare Private Limited — Secnidazole Exporter Profile
Indian Pharmaceutical Exporter · #6 for Secnidazole · $673.4K export value · DGFT Verified
Impact Healthcare Private Limited is the #6 Indian exporter of Secnidazole with $673.4K in export value and 38 verified shipments. Impact Healthcare Private Limited holds a 2.2% market share in Secnidazole exports across 8 countries.
Impact Healthcare Private Limited — Secnidazole Export Profile: Buyers & Destinations
Where Does Impact Healthcare Private Limited Export Secnidazole?
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $537.7K | 18 | 99.1% |
| CHAD | $4.0K | 9 | 0.7% |
| NIGER | $812 | 2 | 0.1% |
| CENTRAL AFRICAN REPUBLIC | $95 | 1 | 0.0% |
| CONGO | $49 | 4 | 0.0% |
| CAMEROON | $24 | 2 | 0.0% |
| MAURITANIA | $24 | 1 | 0.0% |
| SENEGAL | $0 | 1 | 0.0% |
Impact Healthcare Private Limited exports Secnidazole to 8 countries. The largest destination is FRANCE accounting for 99.1% of Impact Healthcare Private Limited's Secnidazole shipments, followed by CHAD (0.7%) and NIGER (0.1%). These destinations reflect Impact Healthcare Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Secnidazole from Impact Healthcare Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PIEX SOCIETE PHARMACEUTIQUE | FRANCE | $320.8K | 9 |
| PIEX SOCIETE PHARMACEUTIQUE, | FRANCE | $173.6K | 7 |
| PIEX SOCIETE PHARMACEUTIQUE DIMPORT EXPORT | FRANCE | $27.5K | 1 |
| PIEX SOCIETE PHARMACEUTIQUE DIMPORT | FRANCE | $15.8K | 1 |
| SIMO PHARMA;MAHAMAT DJEROUA | CHAD | $3.6K | 6 |
| SONIMED S.A | NIGER | $812 | 2 |
| SIMO PHARMA MAHAMAT DJEROUA | CHAD | $260 | 1 |
| SIMO PHARMA MAHAMAT DJEROUA RUE CANAL SAINT MARTIN BOLOLO | CHAD | $158 | 2 |
| PHARMACY PALOMA | CENTRAL AFRICAN REPUBLIC | $95 | 1 |
| O A VISION SANTE;IMMENBLE SOPROGI(P | CONGO | $49 | 4 |
Impact Healthcare Private Limited supplies Secnidazole to 13 buyers globally. The largest buyer is PIEX SOCIETE PHARMACEUTIQUE (FRANCE), followed by PIEX SOCIETE PHARMACEUTIQUE, (FRANCE) and PIEX SOCIETE PHARMACEUTIQUE DIMPORT EXPORT (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Secnidazole Export Value and How Much Does Impact Healthcare Private Limited Contribute?
India exported $8.9M worth of Secnidazole through 652 shipments from 115 suppliers to 77 countries, serving 239 buyers globally. Impact Healthcare Private Limited contributes $673.4K to this total, accounting for 2.2% of India's Secnidazole exports. Impact Healthcare Private Limited ships Secnidazole to 8 countries through 13 buyers.
What Is the Average Shipment Value for Impact Healthcare Private Limited's Secnidazole Exports?
Impact Healthcare Private Limited's average Secnidazole shipment value is $17.7K per consignment, based on 38 shipments totaling $673.4K. The largest destination is FRANCE (99.1% of Impact Healthcare Private Limited's Secnidazole exports).
How Does Impact Healthcare Private Limited Compare to Other Indian Secnidazole Exporters?
Impact Healthcare Private Limited ranks #6 among 115 Indian Secnidazole exporters with a 2.2% market share. The top 3 exporters are CAPLIN POINT LABORATORIES LIMITED ($2.1M), AJANTA PHARMA LIMITED ($2.0M), LINCOLN PHARMACEUTICALS LTD ($950.0K). Impact Healthcare Private Limited processed 38 shipments to 8 destination countries.
What Secnidazole Formulations Does Impact Healthcare Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AFSC KIT2 SECNIDAZOLE 1GM 1AZITHROMYCIN | $50.0K | 1 |
| AFSC KIT (2 SECNIDAZOLE 1GM 1 AZITHROMYCIN USP 1GM 1FLUCONAZOLE 150MG) ANTIFUNGAL DRUG B.NO.I2403005,MFG:11/23,EXP:10/25 | $50.0K | 1 |
| AFSC KIT SIZE : KIT B.NO. I2404002 MFG.DT: 03/2024 EXP.DT. 02/2026 (2 SECNIDAZOLE 1 GM,1 AZITHROMYCIN USP 1 GM, 1 | $50.0K | 1 |
| AFSC KIT SIZE : KIT B.NO. I2404005 MFG.DT. 06/2024 EXP.DT. 05/2026 (2 SECNIDAZOLE 1 GM,1 AZITHROMYCIN USP 1 GM, 1 | $50.0K | 1 |
| AFSC KIT 2 SECNIDAZOLE 1GM 1 AZITHROMYCIN USP 1GM 1 FLUCONAZOLE USP 150MG B NO I2405003 MFG 04 2025 EXP 03 2027 ANTIFUN | $50.0K | 1 |
| AFSC KIT(2 SECNIDAZOLE 1GM,1 AZITHROMYCIN USP 1GM,1 FLUCONAZOLE USP 150MG)B.NO.I2405002,MFG:02/2025,EXP:01/2027(ANTIFUNG | $41.2K | 1 |
| AFSC KIT2 Secnidazole 1Gm,1 Azithromyci | $40.9K | 1 |
| AFSC KIT SIZE : KIT B.NO. I2404003 MFG.DT. 03/2024 EXP.DT. 02/2026 (2 SECNIDAZOLE 1 GM,1 AZITHROMYCIN USP 1 GM, 1 FLUCON | $39.9K | 3 |
| AFSC KIT(2 SECNIDAZOLE 1GM. 1 AZITHROMYCIN USP 1GM,1 FLUCONAZOLE USP 150MG)B.NO.I2405002,MFG:02/2025,EXP:01/2027(ANTIFUN | $33.0K | 1 |
| AFSC KIT SIZE : KIT B.NO. I2404004 MFG.DT. 04/2024 EXP.DT. 03/2026 (2 SECNIDAZOLE 1 GM,1 AZITHROMYCIN USP 1 GM, 1 | $32.8K | 1 |
Impact Healthcare Private Limited exports 32 distinct Secnidazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AFSC KIT2 SECNIDAZOLE 1GM 1AZITHROMYCIN with 1 shipments worth $50.0K.
How Does Impact Healthcare Private Limited Compare to Nearest Secnidazole Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | LINCOLN PHARMACEUTICALS LTD | $950.0K | 19 | 5 | $50.0K |
| 4 | ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED | $850.0K | 17 | 5 | $50.0K |
| 6 | IMPACT HEALTHCARE PRIVATE LIMITED ★ | $673.4K | 38 | 8 | $17.7K |
| 7 | UNICHEM LABORATORIES LIMITED | $459.3K | 39 | 8 | $11.8K |
| 10 | KUSUM HEALTHCARE PRIVATE LIMITED | $295.3K | 44 | 7 | $6.7K |
Impact Healthcare Private Limited ranks #6 among 115 Indian Secnidazole exporters. Average shipment value of $17.7K compared to the market average of $77.0K. The closest competitors by value are LINCOLN PHARMACEUTICALS LTD and ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED.
Which Indian Ports Ship Secnidazole Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 75 | 11.5% |
| SAHAR AIR | 59 | 9.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 57 | 8.7% |
| JNPT/ NHAVA SHEVA SEA | 46 | 7.1% |
| DELHI AIR | 46 | 7.1% |
| JNPT | 34 | 5.2% |
| DELHI AIR CARGO ACC (INDEL4) | 31 | 4.8% |
| AHEMDABAD ICD | 22 | 3.4% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Secnidazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Secnidazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Impact Healthcare Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 38 individual customs records matching Impact Healthcare Private Limited exporting Secnidazole, covering 32 formulations to 8 countries via 13 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 77+ countries, 239+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Secnidazole Export Data from Impact Healthcare Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Impact Healthcare Private Limited's Secnidazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Impact Healthcare Private Limited
Company Profile
0 products · $0 total trade · 0 categories
Secnidazole Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Impact Healthcare Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Secnidazole. For current shipment-level data, contact TransData Nexus.